ALP
AlphaTON Capital Corp.
NASDAQ · Healthcare · Biotechnology · VG
$3.30
−0.90%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.23x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.71x
- Price / sales
- 52.73x
- Price / cash flow
- -0.16x
Enterprise value
- Enterprise value
- $2.7M
- EV / sales
- 28.35x
- EV / EBITDA
- -0.08x
- EV / EBIT
- -0.11x
- Market cap
- $5.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026